Demant A/S (WILYY) Stock Price, News & Analysis

Company Overview

Demant A/S is a Denmark-based hearing healthcare company that develops, manufactures and distributes products and services designed to help people with hearing loss. Its activities span hearing aids, audiological diagnostic equipment, hearing-related communications solutions and professional hearing care services.

The company’s hearing aid portfolio includes brands such as Oticon, Bernafon and Sonic, as well as Philips Hearing Solutions products developed through a licensing partnership. Demant also supplies diagnostic equipment through brands including Interacoustics, MAICO, Grason-Stadler and MedRx. Through hearing care operations and retail networks, including Audika and HearingLife in selected markets, the company provides hearing assessments, fitting, rehabilitation and related patient services.

Founded in 1904 by Hans Demant after he sought a hearing aid for his wife, the company has grown into an international hearing healthcare group headquartered in Smørum, Denmark. It changed its name from William Demant Holding A/S to Demant A/S in 2019. Demant serves customers through operations and distribution networks across Europe, North America, Asia-Pacific and other international markets, with Søren Nielsen serving as president and chief executive officer.

Key Stats

• Today's Range: $22.82 to $22.82
• 50-Day Range: $20.66 to $23.00
• 52-Week Range: $13.45 to $23.00
• Volume: 9 shs
• Average Volume: 116 shs
• Market Capitalization: $9.66 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Moderate Buy

Company Calendar

• Today: 9/12/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:WILYY
• Previous Symbol: NASDAQ:WILYY
• CIK: N/A
• Web: www.demant.com
• Phone: (453) 917-7300
• Fax: 45-3927-8900
• Employees: 26,704
• Year Founded: 1904

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 1.65
• Current Ratio: 1.36
• Quick Ratio: 1.00

Sales & Book Value

• Annual Sales: $3.48 billion
• Price / Sales: 2.78
• Cash Flow: $0.88 per share
• Price / Cash Flow: 25.96
• Book Value: $3.51 per share
• Price / Book: 6.50

Miscellaneous

• Outstanding Shares: 423,510,000
• Free Float: N/A
• Market Cap: $9.66 billion
• Optionable: Not Optionable
• Beta: 1.20